Shownotes
In this episode of Pathfinders, Brian Abrahams, Managing Director and Co-Head of Biotechnology Equity Research at RBC Capital Markets speaks with Andy Schwab, Co-Founder and Managing Partner at 5AM Ventures.
Key Points
- Prescription Digital Therapeutics will be vital to future treatment
- Unlocking microbiome could lead to better disease management